Quinlan Paul T — SEC insider filings

SEC reporting owner CIK 1333277. 25 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers all 25 filings on record, filed 2020-10-14 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Oruka Therapeutics, Inc. (ORKA)General Counsel9—22 legs · 82,505 sh · $8,319,34513
CymaBay Therapeutics, Inc. (CBAY)General Counsel16—11 legs · 93,000 sh · $1,498,31035

Insider filings — Quinlan Paul T

FiledFormIssuerReported transactionsSource
2026-11-204Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 9,000 @ $7.80 · Sale (S): 3,300 @ $94.05 · Sale (S): 3,000 @ $94.77 · Sale (S): 2,500 @ $95.99 · Sale (S): 200 @ $96.60 · Option exercise (M): 9,000 (derivative) @ $0EDGAR
2026-10-204Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 9,000 @ $7.80 · Sale (S): 400 @ $74.90 · Sale (S): 500 @ $76.12 · Sale (S): 1,000 @ $77.20 · Sale (S): 4,100 @ $78.79 · Sale (S): 3,000 @ $79.49 · +1 moreEDGAR
2026-09-214Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 10,000 @ $7.80 · Sale (S): 2,900 @ $92.37 · Sale (S): 3,832 @ $93.32 · Sale (S): 601 @ $94.44 · Sale (S): 2,667 @ $95.31 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2026-09-154Oruka Therapeutics, Inc. (ORKA)Sale (S): 1,039 @ $95.71EDGAR
2026-08-144Oruka Therapeutics, Inc. (ORKA)Option exercise (M): 10,000 @ $7.80 · Option exercise (M): 42,000 @ $12.50 · Sale (S): 3,630 @ $106.05 · Sale (S): 10,434 @ $107.14 · Sale (S): 14,696 @ $107.97 · Sale (S): 10,200 @ $109.11 · +4 moreEDGAR
2026-06-154Oruka Therapeutics, Inc. (ORKA)Sale (S): 733 @ $69.69EDGAR
2026-03-174Oruka Therapeutics, Inc. (ORKA)Sale (S): 733 @ $41.30EDGAR
2026-01-234Oruka Therapeutics, Inc. (ORKA)Grant/award (A): 32,500 @ $0 · Grant/award (A): 130,000 (derivative) @ $0EDGAR
2025-01-244Oruka Therapeutics, Inc. (ORKA)Grant/award (A): 162,500 (derivative) @ $0EDGAR
2024-03-224CymaBay Therapeutics, Inc. (CBAY)Disposition to issuer (D): 41,824 · Disposition to issuer (D): 28,438 · Disposition to issuer (D): 233,176 (derivative) · Disposition to issuer (D): 22,167 (derivative) · Disposition to issuer (D): 107,000 (derivative) · Disposition to issuer (D): 215,000 (derivative) · +1 moreEDGAR
2024-03-154CymaBay Therapeutics, Inc. (CBAY)Option exercise (M): 41,824 @ $7.89 · Option exercise (M): 41,824 (derivative) @ $0EDGAR
2024-01-264CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 28,438 @ $0 · Grant/award (A): 105,625 (derivative) @ $0EDGAR
2024-01-164CymaBay Therapeutics, Inc. (CBAY)Option exercise (M): 5,000 @ $2.94 · Sale (S): 5,000 @ $23.58 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-12-154CymaBay Therapeutics, Inc. (CBAY)Option exercise (M): 5,000 @ $2.94 · Sale (S): 5,000 @ $21.98 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-11-174CymaBay Therapeutics, Inc. (CBAY)Option exercise (M): 5,000 @ $2.94 · Sale (S): 5,000 @ $17.38 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-10-184CymaBay Therapeutics, Inc. (CBAY)Option exercise (M): 5,000 @ $2.94 · Sale (S): 5,000 @ $13.76 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-09-194CymaBay Therapeutics, Inc. (CBAY)Option exercise (M): 5,000 @ $2.94 · Sale (S): 5,000 @ $16.87 · Option exercise (M): 24,000 @ $2.94 · Sale (S): 24,000 @ $16.87 · Option exercise (M): 24,000 @ $2.94 · Sale (S): 24,000 @ $16.87 · +1 moreEDGAR
2023-08-164CymaBay Therapeutics, Inc. (CBAY)Option exercise (M): 5,000 @ $2.94 · Sale (S): 5,000 @ $11.91 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-07-144CymaBay Therapeutics, Inc. (CBAY)Option exercise (M): 5,000 @ $2.94 · Sale (S): 5,000 @ $11.81 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-06-304CymaBay Therapeutics, Inc. (CBAY)Option exercise (M): 5,000 @ $2.94 · Sale (S): 5,000 @ $10.05 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-05-174CymaBay Therapeutics, Inc. (CBAY)Option exercise (M): 5,000 @ $2.94 · Sale (S): 5,000 @ $10.37 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2023-01-274CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 215,000 (derivative) @ $0EDGAR
2022-01-274CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2021-01-284CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 22,167 (derivative) @ $0EDGAR
2020-10-144CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 275,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1333277 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs